cagrilintide/semaglutide Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial Efficacy and safety of co-administered

Consider: daily multivitamin, vitamin D 2,000-4,000 IU daily (most people are deficient), vitamin B12 if energy is low, calcium 1,000-1,200mg daily (especially for women), fiber supplement if constipated, protein powder if struggling to hit 80-100g daily from food

Understanding Research Dose Ranges The dose ranges shown in the peptide half-life chart reflect commonly reported laboratory research values and are not clinical recommendations

Link Kopelevich, V

Tingling or numbness in the extremities, muscle weakness, unsteady gait, balance problems, reduced reflexes, difficulty walking, confusion, dementia, depression, and memory loss can occur